1. Home
  2. MEGI vs CDMO Comparison

MEGI vs CDMO Comparison

Compare MEGI & CDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEGI
  • CDMO
  • Stock Information
  • Founded
  • MEGI 2021
  • CDMO 1981
  • Country
  • MEGI United States
  • CDMO United States
  • Employees
  • MEGI N/A
  • CDMO N/A
  • Industry
  • MEGI Investment Managers
  • CDMO Biotechnology: Pharmaceutical Preparations
  • Sector
  • MEGI Finance
  • CDMO Health Care
  • Exchange
  • MEGI Nasdaq
  • CDMO Nasdaq
  • Market Cap
  • MEGI 764.1M
  • CDMO 784.1M
  • IPO Year
  • MEGI N/A
  • CDMO N/A
  • Fundamental
  • Price
  • MEGI $12.50
  • CDMO $12.36
  • Analyst Decision
  • MEGI
  • CDMO Buy
  • Analyst Count
  • MEGI 0
  • CDMO 5
  • Target Price
  • MEGI N/A
  • CDMO $13.63
  • AVG Volume (30 Days)
  • MEGI 178.0K
  • CDMO 1.3M
  • Earning Date
  • MEGI 01-01-0001
  • CDMO 12-10-2024
  • Dividend Yield
  • MEGI 11.40%
  • CDMO N/A
  • EPS Growth
  • MEGI N/A
  • CDMO N/A
  • EPS
  • MEGI N/A
  • CDMO N/A
  • Revenue
  • MEGI N/A
  • CDMO $150,445,000.00
  • Revenue This Year
  • MEGI N/A
  • CDMO $19.05
  • Revenue Next Year
  • MEGI N/A
  • CDMO $20.88
  • P/E Ratio
  • MEGI N/A
  • CDMO N/A
  • Revenue Growth
  • MEGI N/A
  • CDMO 6.75
  • 52 Week Low
  • MEGI $10.63
  • CDMO $5.65
  • 52 Week High
  • MEGI $14.89
  • CDMO $12.48
  • Technical
  • Relative Strength Index (RSI)
  • MEGI 26.06
  • CDMO 67.27
  • Support Level
  • MEGI $12.32
  • CDMO $12.11
  • Resistance Level
  • MEGI $13.33
  • CDMO $12.39
  • Average True Range (ATR)
  • MEGI 0.23
  • CDMO 0.09
  • MACD
  • MEGI -0.09
  • CDMO -0.05
  • Stochastic Oscillator
  • MEGI 12.26
  • CDMO 89.29

About MEGI MainStay CBRE Global Infrastructure Megatrends Term Fund

MainStay CBRE Global Infrastructure Megatrends Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to seek a high level of total return with an emphasis on current income. It invests predominantly in income-producing equity securities issued by infrastructure companies, including common stock, preferred stock, convertible securities, and rights or warrants to buy common stocks. The company intends to focus on three infrastructure megatrends: decarbonization, digital transformation, and asset modernization while making its investments.

About CDMO Avid Bioservices Inc.

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

Share on Social Networks: